• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 15, 2018 at 10:42: PM
via As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. In a WARN notice posted on the state’s website, Genentech disclosed that it expects to lay off the employees starting at the end of the month.

article source
 




Top Bottom
Back
Quote